Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death

URN to cite this document:: urn:nbn:de:bvb:355-epub-442371
DOI to cite this document:: 10.5283/epub.44237

Luger, Anna-Luisa

; Lorenz, Nadja I. ; Urban, Hans ; Divé, Iris ; Engel, Anna L. ; Strassheimer, Florian ; Dettmer, Katja ; Zeiner, Pia S. ; Shaid, Shabnam ; Struve, Nina ; Kriegs, Malte ; Hofmann, Ute

; Oefner, Peter J. ; Harter, Patrick N. ; Steinbach, Joachim P. ; Ronellenfitsch, Michael W.

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(2MB)

Date of publication of this fulltext: 01 Dec 2020 07:51

Alternative links to fulltext:DOI Pubmed Publisher Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background: The epidermal growth factor receptor (EGFR) signaling pathway is genetically activated in approximately 50% of glioblastomas (GBs). Its inhibition has been explored clinically but produced disappointing results, potentially due to metabolic effects that protect GB cells against nutrient deprivation and hypoxia. Here, we hypothesized that EGFR activation could disable metabolic ...